Annual CFI
$99.70 M
+$250.37 M+166.17%
December 31, 2024
Summary
- As of March 13, 2025, CTMX annual cash flow from investing activities is $99.70 million, with the most recent change of +$250.37 million (+166.17%) on December 31, 2024.
- During the last 3 years, CTMX annual CFI has risen by +$77.21 million (+343.33%).
- CTMX annual CFI is now at all-time high.
Performance
CTMX Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
$15.13 M
-$3.03 M-16.69%
December 31, 2024
Summary
- As of March 13, 2025, CTMX quarterly cash flow from investing activities is $15.13 million, with the most recent change of -$3.03 million (-16.69%) on December 31, 2024.
- Over the past year, CTMX quarterly CFI has dropped by -$3.03 million (-16.69%).
- CTMX quarterly CFI is now -84.84% below its all-time high of $99.82 million, reached on December 31, 2022.
Performance
CTMX Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
$99.70 M
+$2.27 M+2.33%
December 31, 2024
Summary
- As of March 13, 2025, CTMX TTM cash flow from investing activities is $99.70 million, with the most recent change of +$2.27 million (+2.33%) on December 31, 2024.
- Over the past year, CTMX TTM CFI has increased by +$2.27 million (+2.33%).
- CTMX TTM CFI is now -30.41% below its all-time high of $143.26 million, reached on June 30, 2020.
Performance
CTMX TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
CTMX Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +166.2% | -16.7% | +2.3% |
| 3 y3 years | +343.3% | +135.3% | +256.5% |
| 5 y5 years | +25.1% | +135.3% | +256.5% |
CTMX Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +166.2% | -84.8% | +110.3% | at high | +166.2% |
| 5 y | 5-year | at high | +166.2% | -84.8% | +110.3% | -30.4% | +166.2% |
| alltime | all time | at high | +166.2% | -84.8% | +110.1% | -30.4% | +162.4% |
CytomX Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $99.70 M(-166.2%) | $15.13 M(-16.7%) | $99.70 M(+2.3%) |
| Sep 2024 | - | $18.17 M(-15.5%) | $97.43 M(+168.2%) |
| Jun 2024 | - | $21.51 M(-52.1%) | $36.33 M(-11.1%) |
| Mar 2024 | - | $44.88 M(+248.9%) | $40.85 M(-127.1%) |
| Dec 2023 | -$150.67 M(-253.3%) | $12.87 M(-130.0%) | -$150.67 M(+136.5%) |
| Sep 2023 | - | -$42.94 M(-264.9%) | -$63.72 M(+200.7%) |
| Jun 2023 | - | $26.04 M(-117.8%) | -$21.19 M(-55.5%) |
| Mar 2023 | - | -$146.64 M(-246.9%) | -$47.65 M(-148.5%) |
| Dec 2022 | $98.26 M(+336.9%) | $99.82 M(<-9900.0%) | $98.26 M(-5549.8%) |
| Sep 2022 | - | -$410.00 K(-0.5%) | -$1.80 M(-121.6%) |
| Jun 2022 | - | -$412.00 K(-44.0%) | $8.34 M(-122.4%) |
| Mar 2022 | - | -$736.00 K(+200.4%) | -$37.26 M(-265.7%) |
| Dec 2021 | $22.49 M(-220.1%) | -$245.00 K(-102.5%) | $22.49 M(-46.7%) |
| Sep 2021 | - | $9.73 M(-121.2%) | $42.19 M(-173.2%) |
| Jun 2021 | - | -$46.01 M(-178.0%) | -$57.61 M(-252.2%) |
| Mar 2021 | - | $59.01 M(+203.3%) | $37.85 M(-302.2%) |
| Dec 2020 | -$18.72 M(-123.5%) | $19.45 M(-121.6%) | -$18.72 M(-227.5%) |
| Sep 2020 | - | -$90.07 M(-282.1%) | $14.68 M(-89.8%) |
| Jun 2020 | - | $49.45 M(+1925.9%) | $143.26 M(+42.2%) |
| Mar 2020 | - | $2.44 M(-95.4%) | $100.75 M(+26.4%) |
| Dec 2019 | $79.70 M | $52.86 M(+37.3%) | $79.70 M(+86.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2019 | - | $38.51 M(+454.9%) | $42.69 M(+4185.7%) |
| Jun 2019 | - | $6.94 M(-137.3%) | $996.00 K(-90.7%) |
| Mar 2019 | - | -$18.61 M(-217.4%) | $10.70 M(+80.6%) |
| Dec 2018 | $5.93 M(-104.9%) | $15.84 M(-598.2%) | $5.93 M(-103.7%) |
| Sep 2018 | - | -$3.18 M(-119.1%) | -$159.67 M(+13.6%) |
| Jun 2018 | - | $16.65 M(-171.2%) | -$140.55 M(-2.3%) |
| Mar 2018 | - | -$23.38 M(-84.4%) | -$143.86 M(+18.6%) |
| Dec 2017 | -$121.27 M(-364.4%) | -$149.76 M(-1039.3%) | -$121.27 M(-270.9%) |
| Sep 2017 | - | $15.94 M(+19.5%) | $70.94 M(+7.0%) |
| Jun 2017 | - | $13.34 M(-1792.5%) | $66.31 M(+110.6%) |
| Mar 2017 | - | -$788.00 K(-101.9%) | $31.49 M(-31.3%) |
| Dec 2016 | $45.86 M(-135.1%) | $42.45 M(+275.3%) | $45.86 M(-196.7%) |
| Sep 2016 | - | $11.31 M(-152.7%) | -$47.44 M(-17.4%) |
| Jun 2016 | - | -$21.48 M(-258.2%) | -$57.45 M(-11.5%) |
| Mar 2016 | - | $13.58 M(-126.7%) | -$64.94 M(-50.3%) |
| Dec 2015 | -$130.56 M(+7751.0%) | -$50.85 M(-4020.4%) | -$130.56 M(+63.8%) |
| Sep 2015 | - | $1.30 M(-104.5%) | -$79.72 M(-1.6%) |
| Jun 2015 | - | -$28.97 M(-44.3%) | -$81.01 M(+55.7%) |
| Mar 2015 | - | -$52.04 M | -$52.04 M |
| Dec 2014 | -$1.66 M(+127.2%) | - | - |
| Dec 2013 | -$732.00 K | - | - |
FAQ
- What is CytomX Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for CytomX Therapeutics?
- What is CytomX Therapeutics annual CFI year-on-year change?
- What is CytomX Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for CytomX Therapeutics?
- What is CytomX Therapeutics quarterly CFI year-on-year change?
- What is CytomX Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for CytomX Therapeutics?
- What is CytomX Therapeutics TTM CFI year-on-year change?
What is CytomX Therapeutics annual cash flow from investing activities?
The current annual CFI of CTMX is $99.70 M
What is the all time high annual CFI for CytomX Therapeutics?
CytomX Therapeutics all-time high annual cash flow from investing activities is $99.70 M
What is CytomX Therapeutics annual CFI year-on-year change?
Over the past year, CTMX annual cash flow from investing activities has changed by +$250.37 M (+166.17%)
What is CytomX Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of CTMX is $15.13 M
What is the all time high quarterly CFI for CytomX Therapeutics?
CytomX Therapeutics all-time high quarterly cash flow from investing activities is $99.82 M
What is CytomX Therapeutics quarterly CFI year-on-year change?
Over the past year, CTMX quarterly cash flow from investing activities has changed by -$3.03 M (-16.69%)
What is CytomX Therapeutics TTM cash flow from investing activities?
The current TTM CFI of CTMX is $99.70 M
What is the all time high TTM CFI for CytomX Therapeutics?
CytomX Therapeutics all-time high TTM cash flow from investing activities is $143.26 M
What is CytomX Therapeutics TTM CFI year-on-year change?
Over the past year, CTMX TTM cash flow from investing activities has changed by +$2.27 M (+2.33%)